Revive Therapeutics Ltd. engages in the research, development, and commercialization of drugs for disorders and infectious diseases. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Toronto, Canada.
RVV stock hasn't changed in a week, the last month showed zero change in price, over the last year REVIVE THERAPEUTICS LTD. has showed a 64.71% decrease.
RVV net income for the last quarter is −770.62 K CAD, while the quarter before that showed −390.62 K CAD of net income which accounts for −97.28% change. Track more REVIVE THERAPEUTICS LTD. financial stats to get the full picture.
No, RVV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RVV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REVIVE THERAPEUTICS LTD. stock right from TradingView charts — choose your broker and connect to your account.
RVV reached its all-time high on Dec 14, 2020 with the price of 0.920 CAD, and its all-time low was 0.020 CAD and was reached on Jul 10, 2023. See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REVIVE THERAPEUTICS LTD. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REVIVE THERAPEUTICS LTD. stock shows the sell signal. See more of REVIVE THERAPEUTICS LTD. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.